71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial
| Autor: | Bentebibel, S-E., McGrail, D., Wahab, R. Abdel, Kochat, V., Arslan, E., Pazdrak, B., Tahon, N.H., Amaria, R.N., Glitza, I.C., Patel, S., Wong, M.K.K., Tawbi, H.A., Mcquade, J., Davies, M., Bernatchez, C., Burks, J., Rai, K., Ekmekcioglu, S., Lizée, L., Diab, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S242-S242 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|